Sun, Aug 2, 2015
A A A
Welcome asarmad
RSS

Sovereign Wealth Funds Briefing - Categorized | Investment, Market

Temasek puts Medreich stake on the block

Posted on 26 October 2012

Temasek Holdings has appointed NM Rothschild to exit a seven-year-old investment in contract drug maker Medreich, which could attract offers from strategic investors like Blackstone-owned Catalent Pharma Solutions and Perrigo Company besides private equity investors.
Temasek with about 30% stake expects Medreich to be valued at $200-250 million. “While Rothschild has been appointed by Temasek, we know that the promoters of the company may also look for an exit if the valuation expectations are met. It is a potential sellout, but the key is valuation,” said people familiar with process………………………………………..Full Article: Source


 Article link

This post was written by:

VRS - who has written 16802 posts on Opalesque Sovereign Wealth Funds Briefing.


Contact the author

Comments are closed.

banner
August 2015
M T W T F S S
« Jul    
 12
3456789
10111213141516
17181920212223
24252627282930
31